Movicol Vloeibaar Sinaasappelsmaak

Macrogol 3350, the active ingredient in Movicol Vloeibaar Sinaasappelsmaak, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the relief of constipation, occasional irregularity, and for bowel cleansing before medical procedures in adults and children as appropriate.

GNH USA supplies Movicol Vloeibaar Sinaasappelsmaak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Vloeibaar Sinaasappelsmaak, an osmotic laxative, acts on the gastrointestinal tract to facilitate bowel movements.

Constipation: softens stool and promotes regular bowel movements. Occasional constipation: provides temporary relief of irregular bowel habits. Bowel preparation: helps clear the intestinal lumen before diagnostic or surgical procedures.

Movicol Vloeibaar Sinaasappelsmaak may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhoea

Serious or Rare Side Effects: - Electrolyte imbalance (e.g., hypernatremia, hypokalemia) - Severe dehydration - Allergic reactions such as rash or angioedema - Acute renal impairment

Before using Movicol Vloeibaar Sinaasappelsmaak, consider the following precautions to ensure safe and effective therapy.

Renal function: assess kidney status, especially in patients with chronic kidney disease. Electrolyte monitoring: check serum electrolytes in patients at risk of imbalance. Hepatic impairment: use with caution in severe liver disease. Intestinal obstruction: avoid in cases of mechanical blockage of the bowel. Pediatric use: adjust dose carefully and monitor for dehydration. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Movicol Vloeibaar Sinaasappelsmaak can interact with other medicines; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives: may cause excessive fluid loss. - Loop diuretics: increased risk of electrolyte disturbances. - Lithium therapy: altered lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium: may affect absorption of electrolytes. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential impact on renal function. - Warfarin: monitor INR as fluid shifts may influence anticoagulation.